Rentschler Biotechnologie, a contract organization for the development and manufacturing of biopharmaceuticals has recently declared the appointment of Stefan Rampf as new Chief Financial Officer (CFO) effective May 1st, 2016. Stefan Rampf will be responsible for Commercial Management. Stefan has around a decade’s experience as CFO with renowned companies, most recently with ABL Technik Entlackung GmbH, Leutkirch, and, until 2013, with Volvo Financial Services in Frankfurt. Dr. Nikolaus F. Rentschler: “Stefan Rampf convinces through his excellent expertise and strengthens the Top Management of Rentschler Biotechnologie on its successful way. The Supervisory Board and Management Board are very much looking forward to the cooperation.”